Metal nanoparticles as a promising technology in targeted cancer treatment

168Citations
Citations of this article
263Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Traditional anticancer treatments have several limitations, but cancer is still one of the deadliest diseases. As a result, new anticancer drugs are required for the treatment of cancer. The use of metal nanoparticles (NPs) as alternative chemotherapeutic drugs is on the rise in cancer research. Metal NPs have the potential for use in a wide range of applications. Natural or surface-induced anticancer effects can be found in metals. The focus of this review is on the therapeutic potential of metal-based NPs. The potential of various types of metal NPs for tumor targeting will be discussed for cancer treatment. The in vivo application of metal NPs for solid tumors will be reviewed. Risk factors involved in the clinical application of metal NPs will also be summarized.

Cite

CITATION STYLE

APA

Xu, J. J., Zhang, W. C., Guo, Y. W., Chen, X. Y., & Zhang, Y. N. (2022). Metal nanoparticles as a promising technology in targeted cancer treatment. Drug Delivery, 29(1), 664–678. https://doi.org/10.1080/10717544.2022.2039804

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free